Skip to search
Skip to main content
Back to Search
Start Over
??- 123 I-Hexadecanoic acid metabolic probe of cardiomypathy
Authors :
Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; the Section of Pediatric Neurology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Section of Pediatric Cardiology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Department of Neurology, University of Michigan Medical Center, Ann Arbor, USA Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; the Section of Pediatric Neurology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Section of Pediatric Cardiology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Department of Neurology, University of Michigan Medical Center, Ann Arbor, USA; Division of Cardiology, The Montreal General Hospital, 1650 Cedar Avenue, H3G 1A4, Montreal, Quebec, Canada Ann Arbor Das, Sunil K. Kalff, Victor Rabinovitch, Mark A. Rogers, W. Leslie Allen, Richard Rosenthal, Amnon Albers, James Pitt, Bertram Swanson, Dennis P. Mangner, Thomas J. Thral, James H. Beierwaltes, William H. Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; the Section of Pediatric Neurology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Section of Pediatric Cardiology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Department of Neurology, University of Michigan Medical Center, Ann Arbor, USA Division of Nuclear Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; Division of Cardiology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, USA; the Section of Pediatric Neurology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Section of Pediatric Cardiology, Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, USA; Department of Neurology, University of Michigan Medical Center, Ann Arbor, USA; Division of Cardiology, The Montreal General Hospital, 1650 Cedar Avenue, H3G 1A4, Montreal, Quebec, Canada Ann Arbor Das, Sunil K. Kalff, Victor Rabinovitch, Mark A. Rogers, W. Leslie Allen, Richard Rosenthal, Amnon Albers, James Pitt, Bertram Swanson, Dennis P. Mangner, Thomas J. Thral, James H. Beierwaltes, William H.
Publication Year :
2006
Abstract
The utility of??- 123 I-hexadecanoic acid myocardial scintigraphy as a metabolic probe of cardiomyopathies was investigated. Sixteen patients with a variety of cardiomyopathies and myopathies that involve cardiac muscle and ten volunteers were imaged in the postabsorptive state in a 40?? LAO projection after a standard dose of??- 123 I-hexadecanoic acid. An elimination T 1/2 was calculated from the left ventricular myocardial time-activity curve. An uptake index, corrected for chest wall attenuation, was also computed in 7 of 10 volunteers and 8 of 16 patients.
Details
Database :
OAIster
Notes :
En_US
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn894075439
Document Type :
Electronic Resource